ダウンロード数: 409

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
13_175.pdf466.34 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author渡辺, 昌美ja
dc.contributor.author川村, 俊三ja
dc.contributor.author石崎, 充ja
dc.contributor.alternativeWATANABE, Masamien
dc.contributor.alternativeKAWAMURA, Shunzoen
dc.contributor.alternativeISHIZAKI, Mitsuruen
dc.date.accessioned2010-05-24T03:18:28Z-
dc.date.available2010-05-24T03:18:28Z-
dc.date.issued1967-02-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/113096-
dc.description.abstractMethacolimycin (each capsel contains 100 mg strength, 3 mil l i on units of colistin methanesulfonate sodium) was orally administered in order to determine its blood and urine concentrations. Then the drug was given to 26 patients with urinary tract infections to evatuate the clinical effectiveness. The results are summarized as follows. 1) The urinary concentration of this drug in patie n ts having normal renal function was the highest during 2 to 3 hours after oral administration and it decreased after 6 hours. In patients with renal function disturbance, however, the urinary concentration was lower than in patients with normal renal function although a sufficiently high blood concentration was achieved. 2) Among 26 cases given Methacolimycin, marked improvements of subjective symptoms and objective findings were noted in 12 cases. In addition other 7 cases showed some responses, so that a total of 19 cases was proved to be effective. In general, the effectiveness was less pronounced in cases with organic urinary tract changes than without changes. As the relation to the causal organisms, the drug was proved to have a relatively high effectiveness against E. coli and Proteus mirabilis while it had less effect against Staph. aureus and Stanh. enidermidis.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher京都大学医学部泌尿器科学教室ja
dc.publisher.alternativeDepartment of Urology, Faculty of Medicine, Kyoto Univeersityen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectColistin/blood/therapeutic use/urineen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectUrinary Tract Infections/drug therapyen
dc.subject.ndc494.9-
dc.title尿路感染症に対するメタコリマイシンの使用経験ja
dc.title.alternativeUse of methacolimycin for urinary tract infectionsen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume13-
dc.identifier.issue2-
dc.identifier.spage175-
dc.identifier.epage181-
dc.textversionpublisher-
dc.sortkey09-
dc.address東北大学医学部泌尿器科学教室ja
dc.address東北大学医学部泌尿器科学教室ja
dc.address東北大学医学部泌尿器科学教室ja
dc.address.alternativethe Department of Urology, Toholzu University Faculty of Medicine, Sendaien
dc.address.alternativethe Department of Urology, Toholzu University Faculty of Medicine, Sendaien
dc.address.alternativethe Department of Urology, Toholzu University Faculty of Medicine, Sendaien
dc.identifier.pmid5624107-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.13 No.2

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。